Zsolt Cselényi

Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(6):1291-1300

Simplified quantification of [18F]FE-PE2I PET in Parkinson's disease: Discriminative power, test-retest reliability and longitudinal validity during early peak and late pseudo-equilibrium.

Brumberg J; Kerstens V; Cselényi Z; Svenningsson P; Sundgren M; Fazio P; Varrone A

Article: NEURO-ONCOLOGY. 2021;23(4):687-696

Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study.

Jucaite A; Stenkrona P; Cselényi Z; De Vita S; Buil-Bruna N; Varnäs K; Savage A; Varrone A; Johnström P; Schou M; Davison C; Sykes A; Pilla Reddy V; Hoch M; Vazquez-Romero A; Moein MM; Halldin C; Merchant MS; Pass M; Farde L

Article: EJNMMI RESEARCH. 2020;10(1):59

Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung - a test-retest PET study in control subjects.

Cselényi Z; Jucaite A; Kristensson C; Stenkrona P; Ewing P; Varrone A; Johnström P; Schou M; Vazquez-Romero A; Moein MM; Bolin M; Siikanen J; Grybäck P; Larsson B; Halldin C; Grime K; Eriksson UG; Farde L

Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2020;40(4):799-807

A PET study in healthy subjects of brain exposure of 11C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancer.

Varrone A; Varnäs K; Jucaite A; Cselényi Z; Johnström P; Schou M; Vazquez-Romero A; Moein MM; Halldin C; Brown AP; Vishwanathan K; Farde L

Article: NEUROPHARMACOLOGY. 2020;162:107809

The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans.

Varnäs K; Cselényi Z; Arakawa R; Nag S; Stepanov V; Moein MM; Johnström P; Kingston L; Elmore CS; Halldin C; Farde L

Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(2):367-375

PET imaging of [11C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding.

Varnäs K; Cselényi Z; Jucaite A; Halldin C; Svenningsson P; Farde L; Varrone A

Article: EJNMMI RESEARCH. 2019;9(1):9

Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator.

Schou M; Ewing P; Cselenyi Z; Fridén M; Takano A; Halldin C; Farde L

Article: EJNMMI RESEARCH. 2018;8(1):102

Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function.

Plavén-Sigray P; Matheson GJ; Cselényi Z; Jucaite A; Farde L; Cervenka S

Article: MOVEMENT DISORDERS. 2018;33(4):592-599

Nigrostriatal dopamine transporter availability in early Parkinson's disease.

Fazio P; Svenningsson P; Cselényi Z; Halldin C; Farde L; Varrone A

Article: DIABETES. 2018;67(2):182-192

In Vivo Visualization of β-Cells by Targeting of GPR44.

Eriksson O; Johnström P; Cselenyi Z; Jahan M; Selvaraju RK; Jensen-Waern M; Takano A; Sörhede Winzell M; Halldin C; Skrtic S; Korsgren O

Article: NEUROIMAGE. 2017;155:344-353

Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: A test-retest analysis using [11C]SCH-23390.

Matheson GJ; Stenkrona P; Cselényi Z; Plavén-Sigray P; Halldin C; Farde L; Cervenka S

Article: PSYCHOPHARMACOLOGY. 2017;234(4):707-716

GABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humans.

Jucaite A; Cselényi Z; Lappalainen J; McCarthy DJ; Lee C-M; Nyberg S; Varnäs K; Stenkrona P; Halldin C; Cross A; Farde L

Article: BRAIN. 2015;138(Pt 9):2687-2700

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.

Jucaite A; Svenningsson P; Rinne JO; Cselényi Z; Varnäs K; Johnström P; Amini N; Kirjavainen A; Helin S; Minkwitz M; Kugler AR; Posener JA; Budd S; Halldin C; Varrone A; Farde L

Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2015;35(9):1485-1493

Quantification of blood flow-dependent component in estimates of beta-amyloid load obtained using quasi-steady-state standardized uptake value ratio.

Cselényi Z; Farde L

Article: NEUROIMAGE. 2015;112:225-231

Diurnal and seasonal variation of the brain serotonin system in healthy male subjects.

Matheson GJ; Schain M; Almeida R; Lundberg J; Cselényi Z; Borg J; Varrone A; Farde L; Cervenka S

Article: NEUROIMAGE. 2014;103:303-308

Distinct regional age effects on [11C]AZ10419369 binding to 5-HT1B receptors in the human brain.

Nord M; Cselenyi Z; Forsberg A; Rosenqvist G; Tiger M; Lundberg J; Varrone A; Farde L

Article: NEUROINFORMATICS. 2014;12(4):551-562

Evaluation of two automated methods for PET region of interest analysis.

Schain M; Varnäs K; Cselényi Z; Halldin C; Farde L; Varrone A

Article: MOLECULAR IMAGING AND BIOLOGY. 2014;16(2):173-179

Synthesis, radiolabeling, and in vivo pharmacokinetic evaluation of the amyloid beta radioligand [11C]AZD4694 in nonhuman primates.

Schou M; Varnäs K; Sandell J; Johnström P; Cselenyi Z; Svensson S; Nakao R; Amini N; Bergman L; Sumic A; Gulyas B; Lindström-Böö E; Halldin C; Farde L

Article: NEUROIMAGE. 2013;82:160-169

A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 - estimating occupancy in the absence of a reference region.

Kågedal M; Cselényi Z; Nyberg S; Raboisson P; Ståhle L; Stenkrona P; Varnäs K; Halldin C; Hooker AC; Karlsson MO

Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2013;16(10):2235-2244

Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR.

Nyberg S; Jucaite A; Takano A; Kågedal M; Cselényi Z; Halldin C; Farde L

Article: JOURNAL OF NUCLEAR MEDICINE. 2013;54(6):880-886

Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia.

Rowe CC; Pejoska S; Mulligan RS; Jones G; Chan JG; Svensson S; Cselényi Z; Masters CL; Villemagne VL

Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2013;40(4):580-593

Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients.

Forsberg A; Juréus A; Cselényi Z; Eriksdotter M; Freund-Levi Y; Jeppsson F; Swahn B-M; Sandell J; Julin P; Schou M; Andersson J; Johnström P; Varnäs K; Halldin C; Farde L; Svensson S

Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2013;40(2):228-237

Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT.

Schain M; Tóth M; Cselényi Z; Arakawa R; Halldin C; Farde L; Varrone A

Article: NEUROIMAGE. 2012;61(4):849-856

Non-linear mixed effects modelling of positron emission tomography data for simultaneous estimation of radioligand kinetics and occupancy in healthy volunteers.

Kågedal M; Cselényi Z; Nyberg S; Jönsson S; Raboisson P; Stenkrona P; Hooker AC; Karlsson MO

Article: EJNMMI RESEARCH. 2012;2:15

Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects.

Jučaite A; Cselényi Z; Arvidsson A; Ahlberg G; Julin P; Varnäs K; Stenkrona P; Andersson J; Halldin C; Farde L

Article: JOURNAL OF NUCLEAR MEDICINE. 2012;53(3):415-424

Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand.

Cselényi Z; Jönhagen ME; Forsberg A; Halldin C; Julin P; Schou M; Johnström P; Varnäs K; Svensson S; Farde L

Article: NEUROIMAGE. 2012;60(1):800-807

Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.

Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A

Article: NEUROIMAGE. 2011;56(3):1111-1121

Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.

Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C

Article: PSYCHOPHARMACOLOGY. 2011;213(2-3):533-545

Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369.

Varnäs K; Nyberg S; Karlsson P; Pierson ME; Kågedal M; Cselényi Z; McCarthy D; Xiao A; Zhang M; Halldin C; Farde L

Article: SYNAPSE. 2010;64(10):733-741

Radiosynthesis of the candidate beta-amyloid radioligand [(11)C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys.

Andersson JD; Varnäs K; Cselényi Z; Gulyás B; Wensbo D; Finnema SJ; Swahn B-M; Svensson S; Nyberg S; Farde L; Halldin C

Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2009;36(11):1859-1863

Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184.

Nyberg S; Jönhagen ME; Cselényi Z; Halldin C; Julin P; Olsson H; Freund-Levi Y; Andersson J; Varnäs K; Svensson S; Farde L

Article: NEUROIMAGE. 2008;40(3):1287-1295

Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum.

Cervenka S; Bäckman L; Cselényi Z; Halldin C; Farde L

Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2008;264(1-2):9-17

Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients.

Vas A; Shchukin Y; Karrenbauer VD; Cselényi Z; Kostulas K; Hillert J; Savic I; Takano A; Halldin C; Gulyás B

Article: NEUROIMAGE. 2006;32(4):1690-1708

A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635.

Cselényi Z; Olsson H; Halldin C; Gulyás B; Farde L

Article: BRAIN. 2006;129(Pt 8):2017-2028

Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.

Cervenka S; Pålhagen SE; Comley RA; Panagiotidis G; Cselényi Z; Matthews JC; Lai RY; Halldin C; Farde L

Article: COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE. 2005;78(2):141-156

Mapping the dimensionality, density and topology of data: the growing adaptive neural gas.

Cselényi Z

Article: NEUROCHEMISTRY INTERNATIONAL. 2004;45(5):773-781

Joint explorative analysis of neuroreceptor subsystems in the human brain: application to receptor-transporter correlation using PET data.

Cselényi Z; Lundberg J; Halldin C; Farde L; Gulyás B

Article: ORVOSI HETILAP. 2004;145(33):1699-1704

[Comparison of clinical data of two autopsy series, 1938-1951 and 1990-2002, at the Debrecen University Department of Neurology].

Szalma I; Kiss A; Cselényi Z; Hegedus K; Csiba L

Article: MOLECULAR IMAGING AND BIOLOGY. 2004;6(1):17-26

The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo.

McCarron JA; Pike VW; Halldin C; Sandell J; Sóvágó J; Gulyas B; Cselényi Z; Wikström HV; Marchais-Oberwinkler S; Nowicki B; Dollé F; Farde L

Article: ORVOSI HETILAP. 2003;144(46):2271-2276

[Human positron emission tomography with oral 11C-vinpocetine].

Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B

Article: ACTA NEUROLOGICA SCANDINAVICA. 2002;106(6):325-332

PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.

Gulyás B; Halldin C; Sandell J; Karlsson P; Sóvágó J; Kárpáti E; Kiss B; Vas A; Cselényi Z; Farde L

Article: ORVOSI HETILAP. 2002;143(47):2631-2636

[Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study].

Vas A; Sóvágó J; Halldin C; Sandell J; Karlsson P; Kárpáti E; Kiss B; Cselényi Z; Farde L; Gulyás B

Article: NEUROIMAGE. 2002;17(1):47-60

Wavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457.

Cselényi Z; Olsson H; Farde L; Gulyás B

Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2002;29(8):1031-1038

Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.

Gulyás B; Halldin C; Sóvágó J; Sandell J; Cselényi Z; Vas A; Kiss B; Kárpáti E; Farde L

Article: ORVOSI HETILAP. 1999;140(31):1737-1742

[Autoradiography of neurotransmitter receptors in whole human brain hemisphere sections].

Cselényi Z; Håkan H; Csiba L; Gulyás B

Visa fler

Artiklar

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI